Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1976 Apr;29(4):336–340. doi: 10.1136/jcp.29.4.336

Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.

M J Martin, Y B Gordon, S M Ratky, L R Baker, T Chard
PMCID: PMC476058  PMID: 932225

Abstract

A number of conditions have been assessed for the collection of serum samples for the measurement of fibrin(ogen) degradation products using a radioimmunoassay for degradation fragment E, which permits precise quantitation of differences. Blood should be collected using minimal venous occlusion into glass tubes containing 10 mg/ml of epsilon amino caproic acid and allowed to clot at 4 to 20 degrees C for at least 4 hours before centrifugation. The serum may be stored at 4 or -20 degrees C. Samples from patients receiving anticoagulant therapy should be treated with 10 IU of thrombin per ml.

Full text

PDF
336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allington M. J. Detection of fibrin(ogen) degradation products by a latex clumping method. Scand J Haematol Suppl. 1971;13:115–119. doi: 10.1111/j.1600-0609.1971.tb01996.x. [DOI] [PubMed] [Google Scholar]
  2. Almer L. O., Hedner U., Nilsson I. M. Serum fibrin-fibrinogen degradation products in acute myocardial infarction. Lancet. 1972 Apr 29;1(7757):960–960. doi: 10.1016/s0140-6736(72)91525-5. [DOI] [PubMed] [Google Scholar]
  3. Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969 Jul 19;3(5663):137–140. doi: 10.1136/bmj.3.5663.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Briggs J. D., Prentice C. R., Hutton M. M., Kennedy A. C., McNicol G. P. Serum and urine fibrinogen-fibrin-related antigen (F.R.-antigen) levels in renal disease. Br Med J. 1972 Oct 14;4(5832):82–85. doi: 10.1136/bmj.4.5832.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butler M. J., Smith M., Irving M. H., Gordon Y. B., Ratky S. M., Rivers J. W., Hawkey C. The influence of beta-adrenergic blockade upon baseline blood coagulation and fibrinolytic activity and upon the responses to venous occlusion. Thromb Diath Haemorrh. 1975 Sep 30;34(1):169–180. [PubMed] [Google Scholar]
  6. FERREIRA H. C., MURAT L. G. [Free fibrin in the circulation. Immunological test for the identification of free fibrin]. Rev Paul Med. 1961 Aug;59:103–105. [PubMed] [Google Scholar]
  7. Gaffney P. J., Chesterman C. N., Allington M. J. Plasma fibrinogen and its fragments during streptokinase treatment. Br J Haematol. 1974 Feb;26(2):285–293. doi: 10.1111/j.1365-2141.1974.tb00473.x. [DOI] [PubMed] [Google Scholar]
  8. Gordon Y. B., Martin M. J., Landon J., Chard T. The development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol. 1975 Jan;29(1):109–119. doi: 10.1111/j.1365-2141.1975.tb01804.x. [DOI] [PubMed] [Google Scholar]
  9. Gordon Y. B., Martin M. J., McNeile A. T., Chard T. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet. 1973 Nov 24;2(7839):1168–1170. doi: 10.1016/s0140-6736(73)92937-1. [DOI] [PubMed] [Google Scholar]
  10. Henderson A. H., Pugsley D. J., Thomas D. P. Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. Br Med J. 1970 Sep 5;3(5722):545–547. doi: 10.1136/bmj.3.5722.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hyde E., Joyce D., Gurewich V., Flute P. T., Barrera S. Intravascular coagulation during pregnancy and the puerperium. J Obstet Gynaecol Br Commonw. 1973 Dec;80(12):1059–1066. doi: 10.1111/j.1471-0528.1973.tb02980.x. [DOI] [PubMed] [Google Scholar]
  12. Latallo Z. S., Teisseyre E., Wegrzynowicz Z., Kopéc M. Degradation of fibrinogen by proteolytic enzymes. Scand J Haematol Suppl. 1971;13:15–19. doi: 10.1111/j.1600-0609.1971.tb01980.x. [DOI] [PubMed] [Google Scholar]
  13. Marder V. J., Shulman N. R., Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem. 1969 Apr 25;244(8):2111–2119. [PubMed] [Google Scholar]
  14. Merskey C., Johnson A. J., Lalezari P. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. J Clin Invest. 1972 Apr;51(4):903–911. doi: 10.1172/JCI106885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  16. NILEHN J. E., NILSSON I. M. DEMONSTRATION OF FIBRINOLYTIC SPLIT PRODUCTS IN HUMAN SERUM BY AN IMMUNOLOGICAL METHOD IN SPONTANEOUS AND INDUCED FIBRINOLYTIC STATES. Scand J Haematol. 1964;1:313–330. doi: 10.1111/j.1600-0609.1964.tb00029.x. [DOI] [PubMed] [Google Scholar]
  17. Naish P., Clark A. D., Winston R. M., Peters D. K. Serum and urine fibrinogen derivatives in normal pregnancy and preeclampsia. Obstet Gynecol. 1973 Dec;42(6):861–867. [PubMed] [Google Scholar]
  18. Plow E., Edgington T. S. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest. 1973 Feb;52(2):273–282. doi: 10.1172/JCI107183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Satterwhite T. K., Hawiger J., Burklow S. L., Koenig M. G. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods. J Infect Dis. 1973 Apr;127(4):437–441. doi: 10.1093/infdis/127.4.437. [DOI] [PubMed] [Google Scholar]
  20. Stiehm E. R., Kennan A. L., Schelble D. T. Split products of fibrin in maternal serum in the perinatal period. Am J Obstet Gynecol. 1970 Nov 15;108(6):941–945. doi: 10.1016/0002-9378(70)90338-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES